Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 126 entries
Sorted by: Best Match Show Resources per page
Improving anticoagulation of patients with an implantable left ventricular assist device.

BMJ open quality

Sage W, Gottiparthy A, Lincoln P, Tsui SSL, Pettit SJ.
PMID: 30306143
BMJ Open Qual. 2018 Oct 02;7(4):e000250. doi: 10.1136/bmjoq-2017-000250. eCollection 2018.

Patients supported with implantable left ventricular assist devices (LVAD) have a significant risk of bleeding and thromboembolic complications. All patients require anticoagulation with warfarin, aiming for a target international normalised ratio (INR) of 2.5 and most patients also receive...

Cite
Sage W, Gottiparthy A, Lincoln P, et al. Improving anticoagulation of patients with an implantable left ventricular assist device. BMJ Open Qual. 2018;7(4):e000250doi: 10.1136/bmjoq-2017-000250.
Sage, W., Gottiparthy, A., Lincoln, P., Tsui, S. S. L., & Pettit, S. J. (2018). Improving anticoagulation of patients with an implantable left ventricular assist device. BMJ open quality, 7(4), e000250. https://doi.org/10.1136/bmjoq-2017-000250
Sage, William, et al. "Improving anticoagulation of patients with an implantable left ventricular assist device." BMJ open quality vol. 7,4 (2018): e000250. doi: https://doi.org/10.1136/bmjoq-2017-000250
Sage W, Gottiparthy A, Lincoln P, Tsui SSL, Pettit SJ. Improving anticoagulation of patients with an implantable left ventricular assist device. BMJ Open Qual. 2018 Oct 02;7(4):e000250. doi: 10.1136/bmjoq-2017-000250. eCollection 2018. PMID: 30306143; PMCID: PMC6173227.
Copy Download .nbib Format: NLM
Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond.

Diabetes care

Pettitt DJ, Wollitzer AO.
PMID: 30787059
Diabetes Care. 2019 Mar;42(3):359-363. doi: 10.2337/dci18-0056.

No abstract available.

Cite
Pettitt DJ, Wollitzer AO. Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond. Diabetes Care. 2019;42(3):359-363doi: 10.2337/dci18-0056.
Pettitt, D. J., & Wollitzer, A. O. (2019). Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond. Diabetes care, 42(3), 359-363. https://doi.org/10.2337/dci18-0056
Pettitt, David J, and Wollitzer, Alison Okada. "Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond." Diabetes care vol. 42,3 (2019): 359-363. doi: https://doi.org/10.2337/dci18-0056
Pettitt DJ, Wollitzer AO. Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond. Diabetes Care. 2019 Mar;42(3):359-363. doi: 10.2337/dci18-0056. PMID: 30787059.
Copy Download .nbib Format: NLM
Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?.

Cardio-oncology (London, England)

Pettit SD, Kirch R.
PMID: 32154005
Cardiooncology. 2018 Jun 15;4:5. doi: 10.1186/s40959-018-0031-4. eCollection 2018.

The increasing efficacy of cancer therapeutics means that the timespan of cancer therapy administration is undergoing a transition to increasingly long-term settings. Unfortunately, chronic therapy-related adverse health events are an unintended, but not infrequent, outcome of these life-saving therapies....

Cite
Pettit SD, Kirch R. Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?. Cardiooncology. 2018;4:5doi: 10.1186/s40959-018-0031-4.
Pettit, S. D., & Kirch, R. (2018). Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?. Cardio-oncology (London, England), 45. https://doi.org/10.1186/s40959-018-0031-4
Pettit, Syril D, and Kirch, Rebecca. "Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?." Cardio-oncology (London, England) vol. 4 (2018): 5. doi: https://doi.org/10.1186/s40959-018-0031-4
Pettit SD, Kirch R. Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?. Cardiooncology. 2018 Jun 15;4:5. doi: 10.1186/s40959-018-0031-4. eCollection 2018. PMID: 32154005; PMCID: PMC7048033.
Copy Download .nbib Format: NLM
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.

Scientific reports

Holme H, Gulati A, Brough R, Fleuren EDG, Bajrami I, Campbell J, Chong IY, Costa-Cabral S, Elliott R, Fenton T, Frankum J, Jones SE, Menon M, Miller R, Pemberton HN, Postel-Vinay S, Rafiq R, Selfe JL, von Kriegsheim A, Munoz AG, Rodriguez J, Shipley J, van der Graaf WTA, Williamson CT, Ryan CJ, Pettitt S, Ashworth A, Strauss SJ, Lord CJ.
PMID: 30131505
Sci Rep. 2018 Aug 21;8(1):12771. doi: 10.1038/s41598-018-30922-8.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Cite
Holme H, Gulati A, Brough R, et al. Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness. Sci Rep. 2018;8(1):12771doi: 10.1038/s41598-018-30922-8.
Holme, H., Gulati, A., Brough, R., Fleuren, E. D. G., Bajrami, I., Campbell, J., Chong, I. Y., Costa-Cabral, S., Elliott, R., Fenton, T., Frankum, J., Jones, S. E., Menon, M., Miller, R., Pemberton, H. N., Postel-Vinay, S., Rafiq, R., Selfe, J. L., von Kriegsheim, A., Munoz, A. G., Rodriguez, J., Shipley, J., van der Graaf, W. T. A., Williamson, C. T., Ryan, C. J., Pettitt, S., Ashworth, A., Strauss, S. J., & Lord, C. J. (2018). Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness. Scientific reports, 8(1), 12771. https://doi.org/10.1038/s41598-018-30922-8
Holme, Harriett, et al. "Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness." Scientific reports vol. 8,1 (2018): 12771. doi: https://doi.org/10.1038/s41598-018-30922-8
Holme H, Gulati A, Brough R, Fleuren EDG, Bajrami I, Campbell J, Chong IY, Costa-Cabral S, Elliott R, Fenton T, Frankum J, Jones SE, Menon M, Miller R, Pemberton HN, Postel-Vinay S, Rafiq R, Selfe JL, von Kriegsheim A, Munoz AG, Rodriguez J, Shipley J, van der Graaf WTA, Williamson CT, Ryan CJ, Pettitt S, Ashworth A, Strauss SJ, Lord CJ. Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness. Sci Rep. 2018 Aug 21;8(1):12771. doi: 10.1038/s41598-018-30922-8. PMID: 30131505; PMCID: PMC6104100.
Copy Download .nbib Format: NLM
Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation.

Cartilage

Pettit RJ, Everhart JS, DiBartola AC, Blackwell RE, Flanigan DC.
PMID: 34894761
Cartilage. 2021 Dec 11;19476035211063866. doi: 10.1177/19476035211063866. Epub 2021 Dec 11.

OBJECTIVE: The objective of this study was to assess potential risk factors, including time delay until implantation, for knee cartilage defect expansion or new high-grade defect formation between biopsy and Autologous Chondrocyte Implantation (ACI) or Matrix Autologous Chondrocyte Implantation...

Cite
Pettit RJ, Everhart JS, DiBartola AC, et al. Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation. Cartilage. 2021;19476035211063866doi: 10.1177/19476035211063866.
Pettit, R. J., Everhart, J. S., DiBartola, A. C., Blackwell, R. E., & Flanigan, D. C. (2021). Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation. Cartilage, 19476035211063866. https://doi.org/10.1177/19476035211063866
Pettit, Robert J, et al. "Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation." Cartilage vol. (2021): 19476035211063866. doi: https://doi.org/10.1177/19476035211063866
Pettit RJ, Everhart JS, DiBartola AC, Blackwell RE, Flanigan DC. Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation. Cartilage. 2021 Dec 11;19476035211063866. doi: 10.1177/19476035211063866. Epub 2021 Dec 11. PMID: 34894761.
Copy Download .nbib Format: NLM
Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation.

Clinical transplantation

Reddy SA, Khialani BV, Lambert B, Floré V, Brown AJ, Pettit SJ, West NE, Lewis C, Parameshwar J, Bhagra S, Kydd A, Hoole SP.
PMID: 34724254
Clin Transplant. 2021 Nov 01;e14523. doi: 10.1111/ctr.14523. Epub 2021 Nov 01.

BACKGROUND: Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) improve sensitivity of cardiac allograft vasculopathy (CAV) detection compared to invasive coronary angiography (ICA), but their ability to predict clinical events is unknown. We determined whether severe CAV detected with...

Cite
Reddy SA, Khialani BV, Lambert B, et al. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation. Clin Transplant. 2021;e14523doi: 10.1111/ctr.14523.
Reddy, S. A., Khialani, B. V., Lambert, B., Floré, V., Brown, A. J., Pettit, S. J., West, N. E., Lewis, C., Parameshwar, J., Bhagra, S., Kydd, A., & Hoole, S. P. (2021). Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation. Clinical transplantation, e14523. https://doi.org/10.1111/ctr.14523
Reddy, S Ashwin, et al. "Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation." Clinical transplantation vol. (2021): e14523. doi: https://doi.org/10.1111/ctr.14523
Reddy SA, Khialani BV, Lambert B, Floré V, Brown AJ, Pettit SJ, West NE, Lewis C, Parameshwar J, Bhagra S, Kydd A, Hoole SP. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation. Clin Transplant. 2021 Nov 01;e14523. doi: 10.1111/ctr.14523. Epub 2021 Nov 01. PMID: 34724254.
Copy Download .nbib Format: NLM
Structural Studies on the Shapeshifting Murine Norovirus.

Viruses

Sherman MB, Williams AN, Smith HQ, Pettitt BM, Wobus CE, Smith TJ.
PMID: 34834968
Viruses. 2021 Oct 26;13(11). doi: 10.3390/v13112162.

Noroviruses are responsible for almost a fifth of all cases of gastroenteritis worldwide. The calicivirus capsid is composed of 180 copies of VP1 with a molecular weight of ~58 kDa. This coat protein is divided into the N-terminus (N),...

Cite
Sherman MB, Williams AN, Smith HQ, et al. Structural Studies on the Shapeshifting Murine Norovirus. Viruses. 2021;13(11)doi: 10.3390/v13112162.
Sherman, M. B., Williams, A. N., Smith, H. Q., Pettitt, B. M., Wobus, C. E., & Smith, T. J. (2021). Structural Studies on the Shapeshifting Murine Norovirus. Viruses, 13(11), . https://doi.org/10.3390/v13112162
Sherman, Michael B, et al. "Structural Studies on the Shapeshifting Murine Norovirus." Viruses vol. 13,11 (2021). doi: https://doi.org/10.3390/v13112162
Sherman MB, Williams AN, Smith HQ, Pettitt BM, Wobus CE, Smith TJ. Structural Studies on the Shapeshifting Murine Norovirus. Viruses. 2021 Oct 26;13(11). doi: 10.3390/v13112162. PMID: 34834968; PMCID: PMC8621758.
Copy Download .nbib Format: NLM
Predicting Maximal Oxygen Uptake Using the 3-Minute All-Out Test in High-Intensity Functional Training Athletes.

Sports (Basel, Switzerland)

Dexheimer JD, Brinson SJ, Pettitt RW, Schroeder ET, Sawyer BJ, Jo E.
PMID: 33266118
Sports (Basel). 2020 Nov 30;8(12). doi: 10.3390/sports8120155.

Maximal oxygen uptake (VO

Cite
Dexheimer JD, Brinson SJ, Pettitt RW, et al. Predicting Maximal Oxygen Uptake Using the 3-Minute All-Out Test in High-Intensity Functional Training Athletes. Sports (Basel). 2020;8(12)doi: 10.3390/sports8120155.
Dexheimer, J. D., Brinson, S. J., Pettitt, R. W., Schroeder, E. T., Sawyer, B. J., & Jo, E. (2020). Predicting Maximal Oxygen Uptake Using the 3-Minute All-Out Test in High-Intensity Functional Training Athletes. Sports (Basel, Switzerland), 8(12), . https://doi.org/10.3390/sports8120155
Dexheimer, Joshua D, et al. "Predicting Maximal Oxygen Uptake Using the 3-Minute All-Out Test in High-Intensity Functional Training Athletes." Sports (Basel, Switzerland) vol. 8,12 (2020). doi: https://doi.org/10.3390/sports8120155
Dexheimer JD, Brinson SJ, Pettitt RW, Schroeder ET, Sawyer BJ, Jo E. Predicting Maximal Oxygen Uptake Using the 3-Minute All-Out Test in High-Intensity Functional Training Athletes. Sports (Basel). 2020 Nov 30;8(12). doi: 10.3390/sports8120155. PMID: 33266118; PMCID: PMC7760774.
Copy Download .nbib Format: NLM
Equity of Access to National Advanced Heart Failure Services.

Circulation. Heart failure

Pettit SJ, Erhayiem B.
PMID: 34465128
Circ Heart Fail. 2021 Oct;14(10):e008745. doi: 10.1161/CIRCHEARTFAILURE.121.008745. Epub 2021 Sep 01.

No abstract available.

Cite
Pettit SJ, Erhayiem B. Equity of Access to National Advanced Heart Failure Services. Circ Heart Fail. 2021;14(10):e008745doi: 10.1161/CIRCHEARTFAILURE.121.008745.
Pettit, S. J., & Erhayiem, B. (2021). Equity of Access to National Advanced Heart Failure Services. Circulation. Heart failure, 14(10), e008745. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008745
Pettit, Stephen J, and Erhayiem, Bara. "Equity of Access to National Advanced Heart Failure Services." Circulation. Heart failure vol. 14,10 (2021): e008745. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008745
Pettit SJ, Erhayiem B. Equity of Access to National Advanced Heart Failure Services. Circ Heart Fail. 2021 Oct;14(10):e008745. doi: 10.1161/CIRCHEARTFAILURE.121.008745. Epub 2021 Sep 01. PMID: 34465128.
Copy Download .nbib Format: NLM
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial.

Cancer discovery

Carreira S, Porta N, Arce-Gallego S, Seed G, Llop-Guevara A, Bianchini D, Rescigno P, Paschalis A, Bertan C, Baker C, Goodall J, Miranda S, Riisnaes R, Figueiredo I, Ferreira A, Pereira R, Crespo M, Gurel B, Nava Rodrigues D, Pettitt SJ, Yuan W, Serra V, Rekowski J, Lord CJ, Hall E, Mateo J, de Bono JS.
PMID: 34045297
Cancer Discov. 2021 Nov;11(11):2812-2827. doi: 10.1158/2159-8290.CD-21-0007. Epub 2021 May 27.

PARP inhibitors are approved for treating advanced prostate cancers (APC) with various defective DNA repair genes; however, further studies to clinically qualify predictive biomarkers are warranted. Herein we analyzed TOPARP-B phase II clinical trial samples, evaluating whole-exome and low-pass...

Cite
Carreira S, Porta N, Arce-Gallego S, et al. Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial. Cancer Discov. 2021;11(11):2812-2827doi: 10.1158/2159-8290.CD-21-0007.
Carreira, S., Porta, N., Arce-Gallego, S., Seed, G., Llop-Guevara, A., Bianchini, D., Rescigno, P., Paschalis, A., Bertan, C., Baker, C., Goodall, J., Miranda, S., Riisnaes, R., Figueiredo, I., Ferreira, A., Pereira, R., Crespo, M., Gurel, B., Nava Rodrigues, D., Pettitt, S. J., Yuan, W., Serra, V., Rekowski, J., Lord, C. J., Hall, E., Mateo, J., & de Bono, J. S. (2021). Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial. Cancer discovery, 11(11), 2812-2827. https://doi.org/10.1158/2159-8290.CD-21-0007
Carreira, Suzanne, et al. "Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial." Cancer discovery vol. 11,11 (2021): 2812-2827. doi: https://doi.org/10.1158/2159-8290.CD-21-0007
Carreira S, Porta N, Arce-Gallego S, Seed G, Llop-Guevara A, Bianchini D, Rescigno P, Paschalis A, Bertan C, Baker C, Goodall J, Miranda S, Riisnaes R, Figueiredo I, Ferreira A, Pereira R, Crespo M, Gurel B, Nava Rodrigues D, Pettitt SJ, Yuan W, Serra V, Rekowski J, Lord CJ, Hall E, Mateo J, de Bono JS. Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial. Cancer Discov. 2021 Nov;11(11):2812-2827. doi: 10.1158/2159-8290.CD-21-0007. Epub 2021 May 27. PMID: 34045297.
Copy Download .nbib Format: NLM
From expert to coach: health coaching to support behavior change within physical therapist practice.

Physiotherapy theory and practice

Rethorn ZD, Bezner JR, Pettitt CD.
PMID: 34620046
Physiother Theory Pract. 2021 Oct 07;1-16. doi: 10.1080/09593985.2021.1987601. Epub 2021 Oct 07.

No abstract available.

Cite
Rethorn ZD, Bezner JR, Pettitt CD. From expert to coach: health coaching to support behavior change within physical therapist practice. Physiother Theory Pract. 2021;1-16doi: 10.1080/09593985.2021.1987601.
Rethorn, Z. D., Bezner, J. R., & Pettitt, C. D. (2021). From expert to coach: health coaching to support behavior change within physical therapist practice. Physiotherapy theory and practice, 1-16. https://doi.org/10.1080/09593985.2021.1987601
Rethorn, Zachary D, et al. "From expert to coach: health coaching to support behavior change within physical therapist practice." Physiotherapy theory and practice vol. (2021): 1-16. doi: https://doi.org/10.1080/09593985.2021.1987601
Rethorn ZD, Bezner JR, Pettitt CD. From expert to coach: health coaching to support behavior change within physical therapist practice. Physiother Theory Pract. 2021 Oct 07;1-16. doi: 10.1080/09593985.2021.1987601. Epub 2021 Oct 07. PMID: 34620046.
Copy Download .nbib Format: NLM
Primary reverse total shoulder arthroplasty performed for glenohumeral arthritis: does glenoid morphology matter?.

Journal of shoulder and elbow surgery

Pettit RJ, Saini SB, Puzzitiello RN, Hart PJ, Ross G, Kirsch JM, Jawa A.
PMID: 34800669
J Shoulder Elbow Surg. 2021 Nov 17; doi: 10.1016/j.jse.2021.10.022. Epub 2021 Nov 17.

BACKGROUND: Indications for reverse total shoulder arthroplasty (RTSA) have expanded to include primary glenohumeral osteoarthritis (GHOA) with an intact rotator cuff. Limited evidence exists on RTSA in patients with primary GHOA and no posterior glenoid wear (Walch A1, A2,...

Cite
Pettit RJ, Saini SB, Puzzitiello RN, et al. Primary reverse total shoulder arthroplasty performed for glenohumeral arthritis: does glenoid morphology matter?. J Shoulder Elbow Surg. 2021;doi: 10.1016/j.jse.2021.10.022.
Pettit, R. J., Saini, S. B., Puzzitiello, R. N., Hart, P. J., Ross, G., Kirsch, J. M., & Jawa, A. (2021). Primary reverse total shoulder arthroplasty performed for glenohumeral arthritis: does glenoid morphology matter?. Journal of shoulder and elbow surgery, . https://doi.org/10.1016/j.jse.2021.10.022
Pettit, Robert J, et al. "Primary reverse total shoulder arthroplasty performed for glenohumeral arthritis: does glenoid morphology matter?." Journal of shoulder and elbow surgery vol. (2021). doi: https://doi.org/10.1016/j.jse.2021.10.022
Pettit RJ, Saini SB, Puzzitiello RN, Hart PJ, Ross G, Kirsch JM, Jawa A. Primary reverse total shoulder arthroplasty performed for glenohumeral arthritis: does glenoid morphology matter?. J Shoulder Elbow Surg. 2021 Nov 17; doi: 10.1016/j.jse.2021.10.022. Epub 2021 Nov 17. PMID: 34800669.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 126 entries